INDOCO

Indoco Remedies Share PriceIndoco Remedies

₹328.25
-1.3 (-0.39%)
As on 10 June, 2023 | 16:00 BSE: 532612 NSE: INDOCO

Indoco Remedies Performance

Day Range

  • Low
  • High
328.25

52 Week Range

  • Low
  • High
328.25
  • Open Price
  • Previous Close
  • Volume

Start SIP in Indoco Remedies

Start SIP

Indoco Remedies Share Price

  • Over 1 Month -2.35%
  • Over 3 Month -4.13%
  • Over 6 Month -15.19%
  • Over 1 Year -12.34%

Indoco Remedies Key Statistics

P/E Ratio 21.3
PEG Ratio -2.6
Market Cap Cr 3,025
Price to Book Ratio 2.9
EPS 15.3
Dividend 0.7
Relative Strength Index 44.18
Money Flow Index 13.27
MACD Signal 1.12
Average True Range 12.33

Indoco Remedies Investment Rating

  • Master Rating:
  • Indoco Remedies has an operating revenue of Rs. 1,668.62 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 12% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Indoco Remedies Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 427399405395400
Operating Expenses Qtr Cr 363337345337328
Operating Profit Qtr Cr 6462887180
Depreciation Qtr Cr 1817162018
Interest Qtr Cr 97543
Tax Qtr Cr 1310181019
Net Profit Qtr Cr 2528503840

Indoco Remedies Technicals

EMA & SMA

Current Price
₹328.25
-1.3 (-0.39%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹337.06
  • 50 Day
  • ₹337.74
  • 100 Day
  • ₹343.69
  • 200 Day
  • ₹353.5
  • 20 Day
  • ₹341.73
  • 50 Day
  • ₹332.65
  • 100 Day
  • ₹343.18
  • 200 Day
  • ₹354.99

Indoco Remedies Resistance and Support

PIVOT
₹330.2
Resistance
First Resistance ₹334.35
Second Resistance ₹339.05
Third Resistance ₹343.2
RSI 44.18
MFI 13.27
MACD Single Line 1.13
MACD -1.04
Support
First Resistance ₹325.5
Second Resistance ₹321.36
Third Resistance ₹316.65

Indoco Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 157,557 4,183,138 26.55
Week 246,842 9,683,627 39.23
1 Month 132,862 5,155,051 38.8
6 Month 185,035 5,699,092 30.8

Indoco Remedies Result Highlights

Indoco Remedies Synopsis

NSE-Medical-Diversified

Indoco Remedies is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1666.69 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2023. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.
Market Cap 3,038
Sales 1,667
Shares in Float 3.78
No of funds 70
Yield 0.68
Book Value 2.95
U/D Vol ratio 0.7
LTDebt / Equity 15
Alpha -0.06
Beta 0.57

Indoco Remedies

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 58.69%58.69%58.69%58.69%
Mutual Funds 17.18%17.28%17.27%17.39%
Insurance Companies 0.11%0.06%0.06%0.13%
Foreign Portfolio Investors 1.55%1.23%1.19%1.17%
Individual Investors 16.48%16.73%16.85%17.22%
Others 5.99%6.01%5.94%5.4%

Indoco Remedies Management

Name Designation
Mr. Suresh G Kare Chairman
Ms. Aditi Panandikar Managing Director
Mr. Sundeep V Bambolkar Joint Managing Director
Dr. Anand Nadkarni Non Executive Director
Mr. D M Gavaskar Independent Director
Mr. Rajiv P Kakodkar Independent Director
Dr.(Ms.) Vasudha V Kamat Independent Director
Mr. Abhijit Y Gore Independent Director

Indoco Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Indoco Remedies Corporate Action

Date Purpose Remarks
2023-05-23 Audited Results & Final Dividend
2023-01-24 Quarterly Results
2022-11-10 Quarterly Results
2022-08-09 Quarterly Results
2022-05-17 Audited Results & Final Dividend

Indoco Remedies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 28779
Franklin India Smaller Companies Fund Growth 8067
HDFC Capital Builder Value Fund Growth 5534
ICICI Prudential Smallcap Fund Growth 5466
Nippon India Pharma Fund - Growth 4564

Indoco Remedies FAQs

What is Share Price of Indoco Remedies ?

Indoco Remedies share price is ₹328 As on 10 June, 2023 | 15:46

What is the Market Cap of Indoco Remedies ?

The Market Cap of Indoco Remedies is ₹3024.8 Cr As on 10 June, 2023 | 15:46

What is the P/E ratio of Indoco Remedies ?

The P/E ratio of Indoco Remedies is 21.3 As on 10 June, 2023 | 15:46

What is the PB ratio of Indoco Remedies ?

The PB ratio of Indoco Remedies is 2.9 As on 10 June, 2023 | 15:46

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number